Target intelligence / Profile preview

Gamma-cyclodextrin (γ-CD)

Target
γ-CD
Molecular classification
Oligosaccharide, Carbohydrate, Cyclic saccharide, (Not a receptor, enzyme, transporter, or canonical drug target)
01

Overview

Gamma-cyclodextrin is a cyclic oligosaccharide composed of eight glucose units linked by α-1,4 glycosidic bonds, forming a truncated cone-shaped ring with a hydrophilic exterior and a hydrophobic interior cavity[2][3][1]. This unique structure enables it to function as a host molecule for hydrophobic guest compounds (such as drugs or cholesterol), enhancing their solubility and stability. It is not a biological drug target (such as a receptor or enzyme); rather, it is widely used in pharmaceuticals, food, and cosmetics as a complexing agent and excipient. The modified form, sugammadex, is used clinically to reverse neuromuscular blockade by encapsulating specific drugs[2]. Gamma-cyclodextrin itself does not possess intrinsic biological signaling functions and is primarily valued for its physical-chemical properties in formulation science[2][1][3][4][5].

Other names
gamma-cyclodextrinγ-cyclodextringamma-dextrincyclooctapentylosecyclooctaamylosecyclomaltooctaosecyclomalto-octaose
02

Mechanism of action

Gamma-cyclodextrin functions as a host molecule for inclusion complexes, increasing the solubility of hydrophobic drugs by trapping them within its hydrophobic cavity. Its derivative, sugammadex, specifically reverses neuromuscular blockade by binding and encapsulating steroidal neuromuscular blocking agents.

03

Biological functions

Complexing agent for drug formulation (increases solubility and bioavailability of compounds)Cholesterol removal (used to filter out cholesterol molecules in biochemical systems)Component for forming host–guest molecular complexesFood additive and pharmaceutical excipient (carrier/stabilizing agent)
04

Disease associations

Used in drug delivery and formulation, not a disease mediator itselfNo direct role in causing or protecting from diseases; applied in drugs and foods for formulation
05

Safety considerations

Generally recognized as safe for use as an excipient; no biological toxicity; biodegradableAs with other cyclodextrins, high systemic exposure may pose a renal risk, but γ-cyclodextrin itself is considered low toxicity
06

Interacting drugs

Sugammadex (a modified γ-cyclodextrin, used as a drug; interacts with rocuronium and vecuronium)

1 more in the full profile.

07

Biomarkers

None (not a molecular target involved in disease pathways)

Beyond the preview

Go deeper on Gamma-cyclodextrin (γ-CD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-cyclodextrin (γ-CD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call